We conducted an analysis with varying cutoffs to examine whether there was a favorable trend in PFS and OS in the EA group, even with different proportions of infusion cutoffs.
← all excerpts
Impact of nivolumab monotherapy infusion time-of-day on short- and long-term outcomes in patients with metastatic gastric cancer.
1
—
—